Archivi categoria: Adiuvante

BO40336

A STUDY COMPARING ADJUVANT ALECTINIB VERSUS ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH ALK POSITIVE NON-SMALL CELL LUNG CANCER (ALINA)

STADIO
IB-IIIA

Il protocollo è attivo nei seguenti centri

Scopri







KEYNOTE-671

EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) WITH PLATINUM DOUBLET CHEMOTHERAPY AS NEOADJUVANT/ADJUVANT THERAPY FOR PARTICIPANTS WITH RESECTABLE STAGE IIB OR IIIA NON-SMALL CELL LUNG CANCER (MK-3475-671)

STADIO
IIB/IIIA

Il protocollo è attivo nei seguenti centri

Scopri





CANOPY-A

A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF CANAKINUMAB VERSUS PLACEBO AS ADJUVANT THERAPY IN ADULT SUBJECTS WITH STAGES AJCC/UICC V. 8 II-IIIA AND IIIB (T>5CM N2) COMPLETELY RESECTED (R0) NON SMALL CELL LUNG CANCER (CACZ885T2301)

STADIO
II/IIIA
IIIB (T>5cm N2)

Il protocollo è attivo nei seguenti centri

Scopri







PEARLS

STUDY OF PEMBROLIZUMAB (MK-3475) VS PLACEBO FOR PARTICIPANTS WITH NON-SMALL CELL LUNG CANCER AFTER RESECTION WITH OR WITHOUT STANDARD ADJUVANT THERAPY (MK-3475-091/KEYNOTE-091)

STADIO
IB; II/IIIA

Il protocollo è attivo nei seguenti centri

Scopri







ADAURA

A PHASE III, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTI-CENTRE, STUDY TO ASSESS THE EFFICACY AND SAFETY OF AZD9291 VERSUS PLACEBO, IN PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION POSITIVE STAGE IB-IIIA NON-SMALL CELL LUNG CARCINOMA, FOLLOWING COMPLETE TUMOUR RESECTION WITH OR WITHOUT ADJUVANT CHEMOTHERAPY 

STADIO
IB-IIIA

Il protocollo è attivo nei seguenti centri

Scopri